PSC Support responds to EMA consultation on behalf of patients
The European Medicines Agency is evaluating clinical trial design in PSC.
Update on PSC from Dr Roger Chapman
An Open Access publication on PSC and an interview with Dr Chapman.
PSC Support at the International Liver Congress 2017
Report about the EASL 2017 International Liver Congress, Amsterdam, April 2017.
VAP-1 in PSC: latest findings published
New and exciting findings about the activity of the enzyme, VAP-1.
Factors affecting clinical course of PSC
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associated With Course of Primary Sclerosing Cholangitis.
Update on the genetics of PSC
New discoveries from an international PSC genetic study open the door to new potential drug targets and trials.
PSC Support Presents Patient Perspective to Regulatory and Research Authorities
Accelerating PSC research and raising the bar.
